Item 7.01. Regulation FD Disclosure

On May 10, 2012, Protalix BioTherapeutics, Inc. (the "Company") issued a press release announcing that senior management will present at three upcoming conferences, as follows:

The Oppenheimer 13th Annual Israeli Conference on Sunday, May 13, 2012 at 1:00 PM IDT. The conference is being held at the David Intercontinental Hotel, Tel-Aviv, Israel.

The TASE & NASDAQ OMX 5th Annual Investor Conference on Thursday, May 17, 2012 at 11:00 AM EDT. The conference will be held at the NASDAQ MarketSite, New York, NY.

The ILSI-Biomed 2012 Conference on Monday, May 21, 2012 at 12:30 PM IDT. The ILSI-Biomed 2012 Conference is being held at the David Intercontinental Hotel, Tel-Aviv, Israel, May 21-23, 2012.

A copy of the press release is furnished as Exhibit 99.1.

The information contained in Item 7.01 of this report and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.